Market Tracker

07/25 4:35pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
5.09 +0.04 / +0.79%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.08 -0.01 / -0.20%
 
Volume: 9.1K

Today’s Trading

Previous close5.05
Today’s open5.01
Day’s range4.96 - 5.10
Volume881,998
Average volume (3 months)1,422,501
Market cap$351.3M
Dividend yield--
Data as of 3:59pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+28.29%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...0.000.00%
GALEGalena Biopharma Inc0.000.00%
NWBONorthwest Biotherape...+0.13+2.07%
RPRXRepros Therapeutics ...-0.14-0.96%
Data as of 3:59pm ET, 07/25/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts